Publications Database

Bertoglio K. et al. (2010)

Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism.

Journal of Alternative and Complementary Medicine

May, 16(5), pp. 555-560

Read Abstract (New Window)

Boris M. , Goldblatt A. , Edelson S. M. (2006)

Improvement in children with autism treated with intravenous gamma globulin.

Journal of Nutritional and Environmental Medicine

15(4), 169-176

Read Abstract (New Window) Read Full (New Window)

Chez M. G. et al. (2000)

Secretin and autism: a two-part clinical investigation.

Journal of Autism and Developmental Disorders

30(2), pp. 87-94

Read Abstract (New Window)

Gupta S. (1999)

Treatment of children with autism with intravenous immunoglobulin.

Journal of Child Neurology

14(3), pp. 203-205

Hilty D. M. , Rodriguez G. D. , Hales R. E. (1998)

Intravenous valproate for rapid stabilization of agitation in neuropsychiatric disorders.

Journal of Neuropsychiatry and Clinical Neurosciences

10(3), pp. 365-366

Read Full (New Window)

American Society of Health-System Pharmacists (2003)

Immune globulin intravenous injection.

Bethesda, MD: U.S. National Library of Medicine

Read Full (New Window)

Roberts W. et al. (2001)

Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.

Pediatrics

107(5), e. 71

Read Abstract (New Window) Read Full (New Window)

Sandler A. D. et al. (1999)

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

New England Journal of Medicine

341(24), pp. 1801-1806

Read Abstract (New Window) Read Full (New Window)

Williams K. J. , Wray J. A. , Wheeler D. M. (2012)

Intravenous secretin for autism spectrum disorders (ASD).

Cochrane Database of Systematic Reviews

4 CD003495.

Read Abstract (New Window) Read Full (New Window)